Inflammatory myofibroblastic tumor of the larynx-a case report.
Do BA, Varshney R, Zawawi F, Levental M, Caglar D, Young J.
J Voice. 2014 Mar;28(2):258-61. doi: 10.1016/j.jvoice.2013.09.004. Epub 2013 Dec 8.
Effect of tumor bulk on local control and survival of patients with T1 glottic cancer.
Reddy SP, Mohideen N, Marra S, Marks JE.
Radiother Oncol. 1998 May;47(2):161-6. doi: 10.1016/s0167-8140(97)00196-5.
Prognostic Potential of the Expression of Podoplanin (D2-40) Within Cells of Squamous Cell Carcinoma of the Larynx and Hypopharynx.
Voelker HU, Hintermeier I, Strehl A, Scheich M.
World J Oncol. 2020 Apr;11(2):65-71. doi: 10.14740/wjon1259. Epub 2020 Mar 29.
Plasmacytoma of the larynx.
Pahor AL.
J Laryngol Otol. 1978 Mar;92(3):223-32. doi: 10.1017/s0022215100085261.
Dietary acrylamide and cancer risk: an updated meta-analysis.
Pelucchi C, Bosetti C, Galeone C, La Vecchia C.
Int J Cancer. 2015 Jun 15;136(12):2912-22. doi: 10.1002/ijc.29339. Epub 2014 Nov 26.
[Inflammatory myofibroblastic tumor of the larynx].
Mijović Z, Mihailović D, Kostov M.
Vojnosanit Pregl. 2008 Oct;65(10):779-82. doi: 10.2298/vsp0810779m.
Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
Krstevska V, Crvenkova S.
Croat Med J. 2006 Feb;47(1):42-52.
Glomangiopericytoma of the Infraorbital Region.
Lee SH, Khalid MAF, Ahmad A, Omar N, Ramli RR.
Head Neck Pathol. 2025 Aug 9;19(1):101. doi: 10.1007/s12105-025-01810-1.
[Analysis of clinical characteristics and treatment outcome of atypical early stage malignant laryngeal tumor].
Luo YT, Du JJ, Yu G, Jiang XJ.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Sep 20;30(18):1467-1469. doi: 10.13201/j.issn.1001-1781.2016.18.010.
Borderline malignant lesions of the larynx.
PUTNEY FJ.
AMA Arch Otolaryngol. 1955 Apr;61(4):381-5. doi: 10.1001/archotol.1955.00720020397001.
